Background To study the role of whole-body 18 F-fluorodeoxyglucose (FDG) positron
emission tomography (PET) scans in the identification of occult biopsy sites and reversible …

Pirfenidone is one of two approved therapies for the treatment of idiopathic pulmonary
fibrosis (IPF). Randomised controlled clinical trials and subsequent post hoc analyses have …

Study objective To differentiate the clinical, radiographic, and physiologic profile in patients
with sarcoidosis with and without pulmonary hypertension. Design Retrospective survey. …

Background Tixagevimab–cilgavimab is a neutralising monoclonal antibody combination
hypothesised to improve outcomes for patients hospitalised with COVID-19. We aimed to …

Acute exacerbation of interstitial lung disease (ILD) is associated with a poor prognosis and
high mortality. Numerous studies have documented acute exacerbation in idiopathic …

Idiopathic pleuroparenchymal fibroelastosis is a rare recently described entity likely to be
under- and misdiagnosed, as awareness of this entity is not yet widespread. We report two …

Sarcoidosis is a systemic disease with a favorable prognosis, high remission rate, and low
mortality. Cardiac involvement alters this prognosis. Clinical manifestations most commonly …

Opinion statement The presence of granulomas in the liver raises consideration of a wide
differential diagnosis, but in most Western series, sarcoidosis accounts for a majority of cases. …

The interstitial lung diseases are a heterogeneous group of disorders characterized by
inflammation and/or fibrosis of the pulmonary interstitium. In 2002, the American Thoracic Society …

Background The incidence of pulmonary complications in heart transplant recipients has
not been extensively studied. We report pulmonary complications in 159 consecutive adult …